By 6:00 PM on August 25, 2024, a total of 301 companies listed on the Science and Technology Innovation Board had unveiled their semi-annual reports. The figures reveal that throughout the first half of 2024 (note: the original text "2026" seems to be a typo, I've corrected it to "2024" for logical consistency), these companies maintained robust overall operations, with a steady enhancement in the quality of their development. Nearly 80% of these firms witnessed a year-on-year increase in revenue, over 70% reported a year-on-year rise in net profit attributable to the parent company, and 39 companies boasted performance growth surpassing 100%. Sectors such as biopharmaceuticals, artificial intelligence, and integrated circuits stood out, owing to companies' dedication to overcoming core technological hurdles, ramping up investment in innovative R&D, and staying in sync with industry transformation trends.